Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2004
02/26/2004US20040038891 Contacting the tissue or organ with an effective amount of an apolipoprotein to treat, prevent or reduce ischemic reperfusion injury
02/26/2004US20040038885 Carriers for administration of active principles such as drugs or nutriments, cosmetic products or plant health products such as herbicides, pesticides, insecticides, fungicides, etc.
02/26/2004US20040038878 Injectable protein formulations
02/26/2004US20040038865 Contacting a proximal face of the membrane or bilayer with a complex comprising the compound and diketopiperazine (DKP), wherein transport of compound from proximal face of the lipid bilayer to a distal face of lipid bilayer is increased
02/26/2004US20040038864 Use of dimethyl sulfone as isotonicity agent
02/26/2004US20040038406 Nanoparticle delivery systems and methods of use thereof
02/26/2004US20040038303 Comprises use of small particle with appropriate hydrophilic-lipophilic-balance value to deliver anticarcinogenic agents to cells and/or tissues; drug screening
02/26/2004US20040037911 Genital lubricating compositions and uses thereof
02/26/2004US20040037907 Parenteral pimaricin as treatment of systemic infections
02/26/2004US20040037897 Treatment of drug resistant organisms
02/26/2004US20040037893 Aqueous composition also including a buffer to keep the pH in the range of 4.0-8.0, a salt of calcium and/or magnesium in a concentration of >15 mM; stabilised against chemical and/ or physical degradation during storage or transportation
02/26/2004US20040037890 Moisture and oxygen stable composition and a process for obtaining said composition
02/26/2004US20040037889 Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
02/26/2004US20040037888 Administering intrarectally or to anorectal region aqueous gel composition containing drug effective in such treatment and carrier comprising water soluble cellulose derivative gelling agent, propylene glycol, water
02/26/2004US20040037885 Amphiphilic diblock copolymer, poorly water-soluble drug, biodegradable polymer, liquid poly(ethylene glycol); composition forms implant containing drug and drug containing polymeric micelles, which are slowly released
02/26/2004US20040037884 Novel dosage forms of risedronate
02/26/2004US20040037883 Controlled release dosage forms
02/26/2004US20040037882 Opioid agonist in a fast dispersing dosage form
02/26/2004US20040037881 Administering composition and dosage form comprising oxybutynin alone/or accompanied by another drug indicated for therapy
02/26/2004US20040037880 Extended release formulation of divalproex sodium
02/26/2004US20040037879 Oral controlled release forms useful for reducing or preventing nicotine cravings
02/26/2004US20040037878 Fast dissolving tablet
02/26/2004US20040037877 Flavored gelatin capsule and method of manufacture
02/26/2004US20040037875 Composition for treatment of inflammatory disorders
02/26/2004US20040037874 Delivery of nucleic acid-like compounds
02/26/2004US20040037873 Norethindrone sustained release formulations and methods associated therewith
02/26/2004US20040037872 Active substance-containing adhesive patch comprising diclofenac or a topically acceptable salt thereof; patch composed of outer impermeable backing layer, matrix layer comprising active substance, removable protective layer
02/26/2004US20040037870 Patch provides volatile substance within solid layer positioned between breathable layer and barrier layer; release liner is removably adhered to barrier layer
02/26/2004US20040037869 Comprises pharmaceutical agent, binder, disintegrant, non-animal product containing flavor or flavor derived from a non-animal source, humectant, granulating solvent, optionally, antioxidants, buffers, preservatives
02/26/2004US20040037819 Non-polymeric hematopoeitic cell clots for delivery of active agents
02/26/2004US20040037809 Intranasal delivery of interferon- beta yielding improved pharmacokinetic and pharmacodynamic results. In certain aspects of the invention, the interferon- beta is delivered to the intranasal mucosa along with one or more intranasal
02/26/2004US20040037797 Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers
02/26/2004US20040037788 A gum, lollipop and lozenge having at least two separate components, with at least one of such components containing amounts of herbal, medicinal and/or mineral elements or combinations thereof to enhance metabolism
02/26/2004US20040037785 Method of making particles for use in a pharmaceutical composition
02/26/2004US20040037784 Particulate (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl) carbonyl)oxy)phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy) acetyl)amino)pentanoyl)amino) propanoic acid or a salt or solvate thereof and one or more suitable excipients for
02/26/2004US20040037783 Pharmaceutical formulation of fluticasone propionate
02/26/2004US20040037778 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic
02/26/2004US20040037766 A skin treatment composition containing ionic calcium and a dermatologically acceptable water-soluble, water-miscible or water-based carrier is provided for treating a skin condition in a mammal, such as dry skin, dry scalp, a burn, sunburn,
02/26/2004DE20318634U1 Topical compositions for preventing or treating rhinitis, comprising sympathomimetic agent with vasoconstrictive and/or mucosal swelling reducing action and glycosaminoglycan to reduce side-effects
02/26/2004DE20220604U1 Zusammensetzung, enthaltend feine Partikel zur Langzeitfreisetzung für schnell in der Mundhöhle zerfallende Tabletten Composition containing fine particles for sustained release of rapidly disintegrating in the oral cavity tablets
02/26/2004DE19834496B4 Verbesserte Freisetzung von Ibuprofen aus Heißschmelzklebemassen in wirkstoffhaltigen Pflastern durch Zusatz von pharmazeutischen Hilfsstoffen und Verwendung von Hilfsstoffen zur Verbesserung der Freisetzung von Ibuprofen Enhanced release of ibuprofen from hot melt adhesives in active substance patches by the addition of pharmaceutical excipients and use of adjuvants to enhance the release of ibuprofen
02/26/2004DE10238162A1 Carrier solution for foods, essential ingredients or dietetically- or pharmacologically-active materials contains a thickener
02/26/2004DE10238161A1 Mucosal or topical administration of minerals, e.g. for treating muscle spasms, psoriasis or osteoporosis or promoting wound healing, comprises direct application of mineral solution from ampoule
02/26/2004DE10237232A1 Aqueous solution for inhalation, useful for treating respiratory disease, contains anticholinergic tricyclo-oxa-aza-nonane derivative and requires no propellant
02/26/2004CA2854798A1 Anti-tnf-alpha antibodies in solution and uses thereof
02/26/2004CA2496044A1 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
02/26/2004CA2495956A1 Sulfonamides as potassium channel blockers
02/26/2004CA2495401A1 Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections
02/26/2004CA2495345A1 Topical anhydrous and ethanol-free ascomycin compositions
02/26/2004CA2495291A1 Galenic formulation for colon targeted delivery of active principles
02/26/2004CA2494756A1 Anti-tnf-alpha antibodies in solution and uses thereof
02/26/2004CA2494580A1 Threaded syringe with quick stop
02/26/2004CA2494147A1 Pharmaceutical compositions for buccal delivery of pain relief medications
02/26/2004CA2494132A1 Pharmaceutical composition, metered dose dispenser containing same, and use of pharmaceutical composition and metered dose dispenser in administering pharmaceutical agent to oral membranes
02/26/2004CA2494002A1 Antigenic compositions
02/25/2004EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
02/25/2004EP1391458A2 Novel method for producing 5-aryloxymethyl-2-oxazolidinones
02/25/2004EP1391426A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate
02/25/2004EP1391214A1 Gene transfer of angiogenic factor for skin disease
02/25/2004EP1391212A1 Oral preparations and supports for oral preparations
02/25/2004EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma
02/25/2004EP1391202A1 Liquid drug preparations
02/25/2004EP1391201A1 Medicinal compositions
02/25/2004EP1391200A1 Drug preparations
02/25/2004EP1390866A2 Container and method for dispensing transdermal dosage forms
02/25/2004EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor
02/25/2004EP1390699A1 Metering method for particulate material
02/25/2004EP1390569A2 Method for manufacture of fine particles
02/25/2004EP1390495A2 Immunostimulatory oligodeoxynucleic molecules
02/25/2004EP1390494A2 Method for stabilising of nucleic acids
02/25/2004EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions
02/25/2004EP1390383A1 Antisense permeation enhancers
02/25/2004EP1390377A1 Crystal forms of azithromycin
02/25/2004EP1390138A1 Vegetable protein-based microcapsules
02/25/2004EP1390085A1 Hydrogel compositions
02/25/2004EP1390084A2 Two-phase, water-absorbent bioadhesive composition
02/25/2004EP1390077A2 Treatment and diagnosis of macrophage mediated disease
02/25/2004EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate
02/25/2004EP1390053A2 Hcg formulation
02/25/2004EP1390048A2 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
02/25/2004EP1390047A1 Taste masking pharmaceutical composition
02/25/2004EP1390044A1 Injectable pamidronate disodium
02/25/2004EP1390041A1 Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
02/25/2004EP1390040A1 Pharmaceutical composition for use in hormone replacement therapy
02/25/2004EP1390039A1 Use of estrogen compounds to increase libido in women
02/25/2004EP1390037A1 Methods for treating delirium using glucocorticoid receptor-specific antagonists
02/25/2004EP1390036A1 Prostanoic acid derivatives as agents for lowering intraocular pressure
02/25/2004EP1390035A1 Method for treating ocular hypertension and glaucoma
02/25/2004EP1390031A2 Topical composition containing a fungicide
02/25/2004EP1390023A2 Pharmaceutical salts
02/25/2004EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route
02/25/2004EP1390019A1 Controlled release drug delivery device
02/25/2004EP1390018A1 A pharmaceutical tablet having a high api content
02/25/2004EP1390016A2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
02/25/2004EP1390015A1 Taste-masking of highly water-soluble drugs
02/25/2004EP1390014A1 Composition and methods for treatment of hyperplasia
02/25/2004EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
02/25/2004EP1390012A1 Novel methods and compositions for delivering macromolecules to or via the respiratory tract
02/25/2004EP1390011A2 Control of compactability through crystallization
02/25/2004EP1390007A1 Cosmetic composition based on zinc and copper sulphates and sucralphate